Partial resistance of primary mouse hepatocytes to lentiviral (LV) vector transduction poses a challenge for ex vivo gene therapy protocols in models of monogenetic liver disease. We thus sought to optimize ex vivo LV gene transfer while preserving the hepatocyte integrity for subsequent transplantation into recipient animals. We found that culture media supplemented with epidermal growth factor (EGF) and, to a lesser extent, hepatocyte growth factor (HGF) markedly improved transduction efficacy at various multiplicities of infection. Up to 87% of primary hepatocytes were transduced in the presence of 10 ng EGF, compared with B30% in standard culture medium (SCMs). The increased number of transgene-expressing cells correlated with increased nuclear import and more integrated pro-viral copies per cell. Higher LV transduction efficacy was not associated with proliferation, as transduction capacity of gammaretroviral vectors remained low (o1%). Finally, we developed an LV transduction protocol for short-term (maximum 24 h) adherent hepatocyte cultures. LV-transduced hepatocytes showed liver repopulation capacities similar to freshly isolated hepatocytes in alb-uPA mouse recipients. Our findings highlight the importance of EGF for efficient LV transduction of primary hepatocytes in culture and should facilitate studies of LV gene transfer in mouse models of monogenetic liver disease.
INTRODUCTION
The liver is a preferred gene therapy target for monogenetic hepatic diseases and for systemic delivery of a therapeutic protein. Clinical examples for the potential application of hepatic gene transfer include, but are not limited to, hemophilia, lysosomal storage disorders, urea cycle defects and a1-antitrypsin deficiency. 1 Persistent expression of the therapeutic gene in hepatocytes by ex vivo or in vivo gene transfer could offer a cure to many of these devastating diseases. More than 15 years ago, the first ex vivo retroviral gene transfer into hepatocytes was attempted in five patients with Familial Hypercholesterolemia. 2 The low transduction rates of primary hepatocytes by murine leukemia virus-based gammaretroviral vectors, however, have limited the therapeutic benefit in these patients, as primary hepatocytes rarely divide and thus restrict the entry of the vector into the nucleus. The discovery that HIV-1-derived lentiviral (LV) vectors transduce non-cycling cells, including primary hepatocytes, much more efficiently than murine leukemia virus-based vectors, has opened new opportunities for persistent hepatic gene therapy. 3 The use of cellular rather than viral promoters in the internal position of the LV allows for constitutional, cell type-specific or inducible expression, and enhances vector safety owing to the usually lower insertional activation of cellular genes by these promoters. 4 The characteristic insertional pattern of LV vectors in gene coding regions and not in promoter sequences, as observed for gammaretroviral vectors, also reduces the risk of insertional upregulation of proto-oncogenes. 5, 6 Although many obstacles for gene therapy of hereditary monogenetic liver diseases still exist, LV vectors thus represent a preferred tool for efficient transduction and persistent expression of the therapeutic gene in recipient hepatocytes by ex vivo or in vivo gene transfer.
Pre-clinical murine models have been developed for many of the monogenetic human liver diseases and shown to be invaluable for pathophysiological and therapeutic studies. 7 Ex vivo hepatic gene therapy requires efficient transduction protocols for isolated primary hepatocytes, which are compatible with subsequent transplantation into recipient hosts. 8 Gene transfer with LV-based vectors into cultured primary mouse hepatocytes is also utilized frequently to study the function of ectopically expressed genes or to express inhibitory RNA for the 'knockdown' of endogenous genes. 9 LV vectors have been shown to transduce primary murine hepatocytes, but do not reach the transduction rates observed in rat and human hepatocytes. With standard culture medium (SCM) it is possible to transduce B20% of a hepatocyte population at a multiplicity of infection (MOI) of 16 . Even by increasing the concentration of virus over 10-fold, transduction rates of not more than 30% have been reached. 10 Here we report, that the cultivation of primary murine hepatocytes in medium containing epidermal growth factor (EGF) significantly increases gene delivery, nuclear import and pro-viral integration of the target gene in primary mouse hepatocytes. Furthermore, we present an efficient ex vivo transduction protocol, which preserves hepatocyte integrity in short-term serum-free cultures and permits transplantation into murine recipients.
RESULTS

Optimized hepatocyte growth medium supports LV transduction
With the aim of improving transduction conditions we tested various culture media for their support of in vitro LV gene transfer to primary hepatocytes. Cells were isolated from C57BL/6 mouse livers, plated on Primaria dishes and transduced 6 h later. Transduction efficacy of a vesicular stomatitis virus G-glycoprotein (VSV-G) 11 pseudotyped LV vector (RRL.PPT.SF.eGFP.pre), which expresses the transgene enhanced green fluorescent protein (eGFP) from the strong viral spleen focus forming enhancer/promoter, 12 was tested by culturing murine hepatocytes in four different media formulations: (1) serum-free SCM containing ascorbic acid, bovine serum albumin, insulin, transferrin and hydrocortisone; (2) hepatocyte growth medium (HGM) where SCM was supplemented with EGF (HGM-E) or hepatocyte growth factor (HGM-H) as indicated; (3) hepatocyte differentiation medium (HDM), which consists of William's E with insulin and dexamethasone; and (4) an optimized medium containing insulin, dexamethasone, bovine serum albumin, ascorbic acid, transferrin, sodium selenite, ethanolamine, linoleic acid, glucose and N-omega -nitro-L-arginine methyl ester. This medium was introduced for hepatocyte cell culture in a recent review on liver cell culture techniques, and shown to preserve hepatocyte function and morphology by Castell and Gomez-Lechon, 13 and has been named Castell medium here.
The transduction rates at an MOI of 10 were similar in SCM, HDM and Castell medium (around 15%), but were significantly higher when primary hepatocytes were cultured in the presence of EGF. The number of transgene-expressing hepatocytes as determined by fluorescence microscopy exceeded 50% of the cells, which showed no impairment of morphology ( Figure 1a) . Quantification by flowcytometric analysis revealed 2.7-to 4.6-fold lower numbers of eGFP-expressing cells in the presence of SCM, HDM and Castell media as compared with HGM-E (average transduction rates were set as 1; Figures 1b and c).
Increased hepatocyte transduction by LV vectors is due to EGF stimulation It was reported previously that a combination of hepatocyte growth factor (HGF) and EGF improves the LV vector-mediated transduction rates and transgene expression in human hepatocytes. 14 We thus hypothesized that the superior transduction rates in the presence of HGM are exclusively mediated by these growth factors. We transduced mouse hepatocytes with our vector in the presence of SCM supplemented with either EGF (25 ng ml À1 ) or HGF (25 ng ml À1 ), or a combination of both growth factors (25 ng ml À1 of each factor). Both proteins, EGF and HGF, significantly increased the number of transgene-expressing cells by 4.2-and 2.2-fold (Po0.05), respectively ( Figure 2a) The combination of both growth factors yielded only a slight increase in eGFP-positive cells, which was statistically indistinguishable from EGF alone. Despite the clear differences regarding the number of eGFP-positive cells in standard and growth factorsupplemented medium, the mean fluorescence intensity remained similar (Supplementary Figure S1) . Furthermore, growth factors of mouse and human origin showed similar efficacy in our experiments (data not shown), reflecting the known cross-reactivity between the species. 15 Lower MOI/transduction ratios as well as absolute numbers of transduction events were reported for cultured primary murine hepatocytes compared with human cells. 10 In view of our gene transfer results in HGM-cultured mouse hepatocytes, we performed a viral dose escalation experiment in either HGM-E (10 ng ml À1 ) or SCM. Murine hepatocytes were transduced with increasing amounts of virus ranging from 1 to 128 infectious particles per cell (Figure 2b ). In the absence of EGF, we observed only a modest gain in transgeneexpressing cells with increasing vector doses. Even at MOIs as high as 128, transduction efficiencies above 50% were never achieved. By contrast, the highest number of eGFP-expressing cells detected in the Stable gene transfer into primary mouse hepatocytes M Rothe et al absence of EGF was already exceeded with four infectious particles per cell in the presence of EGF. With increasing vector doses we were able to achieve transgene expression in over 86% of the cultured hepatocytes (as determined by flow cytometry). To exclude the possibility of pseudo-transduction in our experiments, we also transduced cells in presence of azidothymidine. The reverse transcriptase inhibitor completely abrogated the LV transduction as visualized by fluorescence microscopy (Supplementary Figure S2) or flow cytometry. We now compared primary mouse and human hepatocytes in HGM-E and found almost equal transduction efficiencies (Supplementary Figure S3) . It was reported previously in human hepatocytes that growth factors would also elevate the vector copy numbers in the transduced cells and may therefore increase risks associated with viral toxicity. 14 We analyzed the transduced hepatocytes for the total vector copies per cell. As a vector-derived sequence the woodchuck hepatitis virus post regulatory element (wPRE) element was detected and compared with the intronic genomic sequence of the poly-pyrimidine tract-binding protein-2 (PTBP2) in a multiplex quantitative PCR (qPCR) to calculate the total vector copies per haploid genome. 16 In our experiment, both culture conditions showed a strong dose correlation between total vector copies per cell and increasing amounts of viral vector. Even though the copy numbers per cell increased, we could not confirm elevated levels of total viral DNA in the cells owing to the use of growth factors (Supplementary Figure S4) . To evaluate plasmid contamination in our copy-number analysis, we performed qPCR experiments for the RSV promoter driving the expression of two plasmids. Even though we were able to detect a plasmid-derived signal in the transduced cells (wPRE/RSV ratio B0.08), results for total copy-number detection were not biased as the introduced error was the same for all medium compositions.
Growth factor stimulation has to occur during or shortly after virus transduction Increase of transduction rates of primary murine hepatocytes after EGF stimulation was detected, when the growth factor was supplemented up to 24 h after incubation with the LV. At an MOI of 10 the eGFP transgene was expressed in 28.1 ± 8.1% of the cells cultured in SCM as compared with 51.2 ± 7.6% of cells in cultures having encountered EGF at the time of transduction and continuously throughout the observation period. The percentage of eGFP-expressing hepatocytes (48.7 ± 3.0% eGFP cells) did not change significantly when the growth factor was added 24 h after transduction. An incremental decrease in eGFP-positive cells was detected when the growth factor was added at 48 h or later after transduction (Figure 2c ). The mean fluorescence intensity for all samples, however, remained similar regardless of the time of EGF addition (Supplementary Figure S5) . As several groups use short-term transduction protocols in suspension, we investigated reduced incubation times with EGF and their effects on transduction efficiency. Primary murine hepatocytes were transduced in either SCM or HGM-E at 37 1C and cultured further without growth factor supplementation (after 4 h). 
05). (d). Short-term (16 h
) and ultra-short-term (4 h) transduction (MOI 10) in either HGM-E (10 ng ml À1 ) or SCM. The transduction was either performed in adherence (ad) or suspension (sus). The growth factor was withdrawn after the given time period and hepatocytes were cultured further in SCM. The short-term (overnight) transduction in HGM-E was significantly more efficient than all ultra-short-term protocols. The beneficial effect of EGF on the LV transduction efficiency, however, was also observed when ultra-short-term results in HGM-E were compared with those under the SCM condition, both in adherence as well as in suspension. The data are presented as the means±s.e.m. (n¼3; *Po0.05).
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We performed this 'ultra-short-term' transduction either in suspension or adherence cultures. The results as determined by flow cytometry showed a significant increase in eGFP-expressing cells for all EGF (10 ng ml À1 )-supplemented conditions. The absolute numbers of transgene-expressing cells, however, varied strongly between the different approaches. The 'ultra-short' incubation time of only 4 h reduced the transduction efficiency from 54.7 ± 7.7% (overnight transduction, constant EGF stimulation) to only 16.6 ± 0.2% (4 h, adherence, HGM-E) and 12.4±0.1% (4 h, suspension, SCM) eGFPexpressing cells. The 'ultra-short' transduction in suspension yielded only 12.1 ± 0.9% eGFP-positive cells in HGM-E and 7.0 ± 0.1% in SCM. We also tested overnight transduction (B16 h) in the presence of 10 ng ml À1 EGF and subsequent cultivation in SCM. Even though the difference between the 16-h incubation time as compared with a complete absence of the growth factor was significant (P¼0.027), we could not achieve the same levels of transgene-expressing cells when compared with a constant addition of EGF ( Figure 2d ). The addition of EGF appeared to have both, a short-term and a long-term effect on the LV transduction efficiency. Only the combination, which is the immediate and constant addition, will yield the optimal effect on the LV transduction of primary murine hepatocytes. Optimal dosage of EGF was determined by adding increasing amounts of EGF to SCM starting with 1 ng ml À1 (Supplementary Figure S6 ). It appeared that 10 ng of the growth factor were sufficient to enhance transduction rates significantly, whereas a tenfold lower concentration had no effect (P¼0.45). Further increase of the EGF concentration to 100 ng yielded only slightly elevated levels of eGFPpositive cells, but already negatively affected the polygonal morphology of the cells (data not shown). Concentrations above 100 ng did not further improve gene transfer and aggravated the deteriorating effect on morphology. As a result of these and further dose escalation experiments (data not shown), we conclude 10-25 ng EGF per milliliter medium to be the optimal concentration for efficient LV transduction.
Growth factors increase the metabolic activity of hepatocytes but not their proliferation
To analyze mechanisms for the increase in transgene-positive cells after LV transduction in more detail, we determined the metabolic activity of hepatocytes during the first 72 h in culture. Overall higher metabolic activity of the cells could positively affect the LV reverse transcription process, the transport to the nucleus or the nuclear import of pre-integration complexes. Hepatocytes were cultured in the media SCM, HGM-E or HGM-H (both 25 ng ml À1 ) and analyzed for metabolic activity at 6, 24, 48 and 72 h after plating by colorimetric measurement of the water-soluble tetrazolium (WST) substrate. An increase in mitochondrial enzyme activity indicates higher metabolic activity of the cells and correlates with higher absorbance measurements. The absence of any growth factor in SCM yielded absorbance readings, which were statistically unchanged throughout the observation period. Compared with SCM, both mitogen conditions showed elevated metabolic activities after 6 h of culture before they decreased to similar levels as SCM at 24-and 48-h culture time points. After 72 h both growth factor-treated groups showed significantly higher readings compared with SCM ( Figure 3a) . The initial increase of metabolic activity in the presence of EGF and HGF could thus have an impact on the early steps of the viral life cycle. This hypothesis was supported by increased expression of c-fos (involved in hepatocyte priming) after 4 h as well as higher levels of cyclin-D1 (G 1 -specific cyclin) after 24 h in EGF-containing medium as determined by quantitative real-time PCR. Neither the G 1 -S phase-specific cyclin-E nor the S-phase-specific cyclin-A were detected at any time point (Supplementary Figure S7) . were transduced with an LV vector either in the presence of 10 ng ml À1 EGF (LV EGF) or in the absence of growth factor (LV no GF). We also measured eGFP expression and total vector DNA in hepatocytes after transduction with a conventional gammaretrovirus in the presence of growth factor (g-Retro EGF) and set the results relative to the LV samples. (d) The degree of nuclear import was determined for the vector dose escalation samples described in Figure 2b . The amount of 2-LTR circles in hepatocytes was measured with a primer/probe combination detecting the specific LTR junctions only present in these episomal circles. The Cq values were normalized for the amount of genomic DNA used and set relative to the total vector-derived DNA. The data are presented as the means±s.e.m. (n¼3; *Po0.05).
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Therefore we assume that medium containing EGF might stimulate the hepatocytes to perform a G 0 -to-G 1 transition without further progression of the cell cycle. Additionally, the increase of metabolic activity at 72 h could have an effect on the overall transgene expression. As the growth factors EGF and HGF have been shown to act as direct mitogens for rat hepatocytes in vitro, a similar activity on primary mouse hepatocytes should also increase the nuclear import and integration of gammaretroviral vectors. 17, 18 In case the growth factors would lead to enhanced proliferation, gammaretroviruses should be able to transduce hepatocytes, as they depend on the breakdown of the nuclear membrane during cell division. 19, 20 We hence transduced primary murine hepatocytes by using a gammaretroviral SIN vector with the same expression cassette and pseudotypization as the LV vector at an MOI of 10. As a control we infected hepatocytes with our LV vector in the presence or absence of EGF at the same MOI. After 6 days the cultures were analyzed for the number of eGFP-positive cells. As expected the number of eGFP-positive cells was increased in the presence of HGM-E as compared with SCM for the LV vector. By contrast, the percentage of transgene-positive hepatocytes transduced with the gammaretroviral vector was below 1% indicating that virtually no cell division took place (Figure 3b ). This was in line with the absence of the S-and M-phase-specific cyclins E and A, as well as conventional proliferation experiments, showing not more than 3% 5-ethynyl-2¢-deoxyuridine (EdU) incorporation in hepatocytes in the first 48 h of culture (Supplementary Figure S8) . From this set of experiments we therefore assume that one of the effects of EGF on LV transduction efficacy is mediated by an increase in metabolic/cell activity without activation of hepatocyte proliferation.
Elevated transduction efficacy correlates with increased nuclear import and integration Stimulation with EGF may increase the nuclear import of LV vector DNA and thereby lead to the elevated numbers in eGFP-positive cells. Using the primer/probe combination (wPRE/PTBP2) as described above, various forms of viral DNA in the cell can be detected. These include late reverse transcripts in the cytoplasm, linear or circular episomal forms in the nucleus, or integrated pro-virus. The amount of episomal vector forms containing two long terminal repeats (2-LTR circles) was shown previously to correlate with the magnitude of nuclear vector import. 21 To distinguish 2-LTR circles from the total vector copies, a probe detecting the unique LTR junctions of 2-LTR circles was used as described previously. 22 As mentioned before, the level of total vector-derived DNA per cell was similar for the LV vectors in SCM and HGM-E. Comparing the differences in the transport of pre-integration complexes into the nucleus in SCM-and HGM-E-cultured hepatocytes, we saw 1.6-fold (Po0.025) more 2-LTR circles in the growth factor-treated samples (Figure 3c ). To further validate the hypothesis of increased nuclear import in hepatocytes in the presence of EGF, the samples from the vector dose escalation experiment were analyzed for the amount of 2-LTR circles. The concentration of 2-LTR circles soon reached a plateau in the absence of growth factor, whereas the nuclear import for the EGF-treated samples showed a dose correlation until an MOI of 16 before a higher plateau was reached (Figure 3d ). The lower percentage of eGFP-expressing cells owing to delayed supplementation of medium with EGF during the course of transduction also correlated with a decrease in nuclear import over time (Supplementary Figure S9) . In case EGF results in elevated 2-LTR circles, its effect on integrasedeficient LV (IDLV) vectors should also be beneficial. The stimulation with 10 ng ml À1 EGF resulted in a significant increase in transgeneexpressing cells in hepatocytes transduced with IDLV vectors as analyzed by flow cytometry or 2-LTR circle detection (Po0.05). Fluorescence microscopy also demonstrates that the addition of EGF yields more transgene-expressing cells (Figures 4a-c) .
The formation of 2-LTR circles is only a side product of the main process, which is integration of the pro-viral DNA into the host chromosomes. Tervo et al. 23 used primers specific for the small interspersed nuclear elements, called b1-elements, to quantify integration of LV vectors in murine cells. We thus performed qPCR using b1-specific as well as vector-specific primers, and compared the relative amounts of integrants after transduction in the presence or absence of growth factors. Additionally, the number of eGFP-positive cells, the total vector copies as well as degree of nuclear import was analyzed. The increase of transgene-positive cells was accompanied with elevated levels of nuclear import and the number of integrants. At the same time, the total vector copies/cell was only slightly increased (Figures 5a-d) .
In vitro transduced murine hepatocyte engraft in mouse livers Current protocols for transplantation of LV gene-modified hepatocytes propose a short-term transduction in suspension at 37 1C. In our hands gene transfer in suspension led to low transduction rates and poor viability of liver cells. The overnight transduction protocol of attached primary hepatocytes in HGM-E as described here yielded good efficiencies and preserved the differentiated, polygonal hepatic morphology after 24 h in culture. We finally tested whether those cells could still be transplanted efficiently into recipient animals. Hepatocytes from a C57BL/6J mouse were isolated and plated on six-well Primaria dishes in HGM-E (10 ng ml À1 ) for 2 h before the medium was changed to remove non-attached cells. After 6 h in culture, cells were transduced with LV (MOI 100) in a final volume of HGM-E not exceeding 1 ml. Following overnight transduction, the cells were washed prior to trypsin/EDTA (10Â concentrated) treatment lasting for less then 5 min at 37 1C. After washing, the cells were resuspended in a 50-ml transplantation volume per mouse. A total of 500 000 cells were transplanted intra-splenically into three hetero-and three homozygous alb-uPA-transgenic animals, which is a well-established murine liver repopulation model, at day 9 after birth. 24 In parallel, six uPA animals were transplanted with freshly isolated cells derived from an eGFP-transgenic mouse. 25 The animals were analyzed for repopulation efficiencies after 1 year by macroscopic examination of whole livers and fluorescence microscopy of paraffin sections. We compared the livers of wild-type animals to the phenotypically normal livers of well-repopulated hetero-and homozygous uPA mice (Figure 6a ). Explicit examination of histological slides revealed no abnormalities regarding the parenchymal engraftment of transduced cells, nor any signs of malignant transformation. We further quantified repopulated areas by fluorescence microscopy (Figure 6b ). Multiple fields of serial sections were counted and repopulation efficiencies calculated (Figure 6c ). The percentage of eGFP-positive clusters of the heterozygous control animals accounted for a mean of 36%. The gene-modified cells constituted approximately 18% of the area in liver sections. As the transduced hepatocytes were only 54% positive for eGFP before transplantation, the repopulation efficacy of recipient livers with transduced hepatocytes was similarly efficient as compared with freshly isolated hepatocytes. The same holds true for the homozygous animals, where repopulation reached levels around 46%, in line with previously published data. 24 The transplantation of transduced or eGFP-transgenic hepatocytes into wild-type mice (n¼6 for both), which do not provide the graft with any selective advantage, led to repopulation efficiencies below 1% as expected (Supplementary Figure S10) .
DISCUSSION
In contrast to fetal hepatoblasts and very young hepatocytes, adult mouse hepatocytes are partially refractory to transduction with LV vectors. Even very high MOIs lead to inefficient transgene expression in the target cell population. Our results show that LV gene transfer to primary murine hepatocytes is significantly enhanced by supplementation of the medium with EGF and/or HGF. Additionally, we describe a novel transduction protocol in growth medium for efficient genetic modification and subsequent transplantation of murine hepatocytes.
In most of the studies using LV vectors to transduce primary liver cells, standard media compositions either aimed to preserve the hepatic phenotype or promote gene transfer by reducing the transduction volume or supplementing media with vitamin E. Using the conventional hepatocyte culture conditions, the majority of cells remain refractory to LV gene transfer. Addition of EGF enhanced the gene transfer by LV vectors in a dose-dependent manner. We determined the minimal amount of EGF necessary for improvement of gene transfer. Addition of 10 ng EGF per milliliter of medium in a time window of 24 h seemed to be sufficient to retrieve significant effects not only for integrating but also for integrase-deficient LV vectors. A further delay in growth factor addition beyond 24 h diminished the effect on transduction efficiencies. This effect could be either due to the induction of cell cycling or only due to the activation of hepatocytes without entry of the S-phase. Other groups have shown in vitro hepatocyte proliferation in lowdensity cultures using high concentrations of one or more growth factors. Our cell culture conditions, however, which resulted in improved LV gene transfer, did not induce appreciable cell division rates, which could be due to the very high seeding density used. We could validate this point by our unsuccessful attempts to transduce murine hepatocytes by gammaretroviral vectors, which depend on the division of the target cell, and by conventional proliferation assays. In our WST assays we saw increases in metabolic activity, which could reflect a certain activation of our cells. Korin and Zack 26 described vectors pseudotyped by a CD20-specific envelope. 27 The necessity for stimulation of hepatocytes without the need for cell division is also supported by the fact that EGF treatment during LV transduction had no effect on actively cycling Hepa1-6 hepatoma cells, as the number of eGFP-positive cells and the mean fluorescence intensity remained statistically unaltered (Supplementary Figure S11) . The growth factor can probably not further increase the metabolic activity of dividing cells, nor can it increase the nuclear import as the nuclear membrane is dissembled during mitosis. The growth factors could affect the reorganization of the microtubule and/or the actin network, necessary for efficient trafficking of the vector from the cell periphery to the nuclear membrane. 28 Cytoskeletal rearrangement was proposed to cause improved gene transfer of LVs with measles virus envelopes that could even transduce cells in G 0 . 27, 29 Apart from its role in signal transduction, the EGF receptor was also reported to be shuttled into the nucleus after EGF stimulation. Interactions between EGF receptor and importin-b increased the import of the receptor into the nucleus, where it can Stable gene transfer into primary mouse hepatocytes M Rothe et al act as a transcription factor. 30, 31 It is possible that LV vectors use similarly regulated EGF-sensitive nuclear transport mechanisms.
Although the mechanisms, how EGF facilitates gene transfer into hepatocytes, are not entirely clear, we observed elevated levels of nuclear vector import. This is indicated by elevated levels of 2-LTR circles, which have been described as specific episomal vector forms and represent canonical indicators for nuclear uptake of pre-integration complexes. A delayed supplementation with EGF resulted in decreased levels of both eGFP-expressing cells in flow cytometry and nuclear import as measured by qPCR. The difference between the SCM condition and delayed EGF addition resulted in a significant decrease in 2-LTR circles as early as 24 h. In the ultra-short-term experiments, where we see a beneficial effect of EGF on LV gene transfer, the number of eGFP-positive cells was reduced compared with constant growth factor treatment. Together with the fact that a 96-h-delayed growth factor addition still led to slightly more eGFPexpressing cells, whereas, at the same time, nuclear import remained unaffected, we hypothesize a dual role of EGF on LV transduction efficiency. The increase in transgene-positive cells is probably due to an early effect resulting in elevated levels of integrated and episomal vectors, as well as a later, globally enhanced metabolic activity due to stimulation with growth factor.
Selden et al. 14 concluded that growth factor stimulation leads to increased vector copy numbers in transduced human hepatocytes. While the situation could be different for cells of human origin, they did not distinguish between the various possible forms of viral DNA in hepatocytes. In line with published protocols, we used three different approaches to measure the various vector forms. These can either be late reverse transcripts, integrated pro-virus or episomal forms. The total vector copies per cell were determined by measuring the wPRE sequence present in all vector-derived DNAs. In addition, we differentiated copies measured by LTR junctions only present in the 2-LTR circles or b1-elements accounting for differences of integrated provirus. Owing to the fact that we measured similar amounts of total vector-derived DNA in all samples, even in the gammaretrovirustransduced cells, we assume that the viral entry of VSV-G-pseudotyped particles into hepatocytes was not influenced by growth factor treatment. Even though the total vector DNA remained similar, the amounts of 2-LTR circles and integrants differed significantly when comparing hepatocytes that were treated either with growth factor or with SCM condition, only. The number of viral particles needed to result in transgene expression in the same amount of target cells is reduced to one half when EGF is used during gene transfer. The possibility to work with reduced MOIs in ex vivo gene therapy also reduces the risk of vector-induced insertional mutagenesis.
The in vitro transduction in EGF-containing media is simple and efficient. Commercially available media (such as HCM) containing EGF and other supplements important for hepatocyte functionality fulfilled all the requirements for improved gene transfer to hepatocytes. After overnight incubation with EGF, the hepatocytes showed no alteration in morphology as compared with cells grown in the absence of growth factor. After in vitro transduction, the phenotypically normal hepatocytes can be transplanted with repopulation levels similar to those achieved with freshly isolated wild-type hepatocytes. The successful repopulation of homozygous uPA mice, which otherwise would have died owing to sub-acute liver failure, indicates a preserved hepatic functionality of the cultured cells. Other groups used very short incubation periods in suspension to reduce in vitro manipulation time. Although ultra-short-term in vitro treatment may be desirable, the proposed suspension transduction for 4 h at 37 1C was much less efficient (3.8-fold difference) as compared with overnight transduction in adherence. Additionally, short-term ex vivo transductions involve the risk of LV vector persistence at the plasma membrane and the carryover of infectious particles to transplanted recipients. O'Neill et al. 32 showed that this effect systematically decreases with prolonged time of transduction up to 24 h.
In conclusion, the growth factor EGF can overcome the limitations in LV gene transfer to murine hepatocytes and opens new possibilities for the modification of their function. The hepatocytes of the most important murine metabolic liver disease models can now be used efficiently for experiments of small interfering RNA knockdown or conventional overexpression of genes of interest. Our study also provides an easy-to-establish protocol for efficient transduction of fully transplantable primary murine hepatocytes. Future approaches should determine the critical steps in EGF signaling, which are responsible for the effects on LV gene transfer.
MATERIALS AND METHODS
LV and gammaretroviral vector production
Retroviral transduction experiments were conducted by using either the integrase-competent, self-inactivating (SIN) LV vector pRRL.PPT.SF.eGFP.pre*, 16, 33 the integrase-deficient LV vector mutant pcDNA.GP/D64.4xCTE or the gammaretroviral vector pSRS11.SF.GFPpre. The vectors were pseudotyped with VSV-G and produced using 293T cells as described previously. 11, 34, 35 Supernatants were concentrated by centrifugation using Centricon Plus-70 Centrifugal Filter Units (Millipore, Schwalbach, Germany) as described before. 36 Viral titers were determined on Hepa1-6 cells by flow cytometry and in the range of 10 7 -10 8 IU ml À1 .
Isolation of primary mouse hepatocytes
Murine hepatocytes were isolated from either C57BL/6J or C57BL/6-Tg(ACTB-EGFP)1Osb/J-transgenic mice by a modified two-step collagenase perfusion procedure. 25, 37 Briefly, liver was first perfused with a liver perfusion medium (Invitrogen, Darmstadt, Germany) using a pump rate of 8 ml min À1 . Subsequently, a liver digest medium (Invitrogen) was applied for enzymatic digestion of tissue at 37 1C, supplemented with Serva Collagenase NB-4 (Serva Electrophoresis GmbH, Heidelberg, Germany) at concentrations of 400-480 mg l À1 depending on the lot-specific properties. After digestion, the tissue was manually disrupted with sterile scissors and scalpels in Williams E Medium (PAN Biotech, Aidenbach, Germany). To separate undigested tissue pieces, the suspended hepatocytes were passed through a 100-mm nylon filter into 50-ml Falcon tubes. The cell suspensions were centrifuged twice at 50 g for 5 min at 4 1C, and the cell pellet was resuspended in Williams E Medium. An aliquot of the cell preparation was separated for cell count and viability analysis (light microscopy and Trypan blue exclusion test). Isolated human hepatocytes were obtained from Cytonet (Hannover, Germany).
Cell culture and transduction
Hepa1-6 and 293T cell lines were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 2 mmol l À1 glutamine and 100 U ml À1 penicillin/streptomycin (Biochrom, Berlin, Germany). In order to determine the number of infectious particles per milliliter, serial dilutions of vector-containing supernatant in Dulbecco's modified Eagle's medium containing the supplements described above and additionally 4 mg ml À1 protamine sulfate (Sigma Aldrich, Munich, Germany) were prepared.
Hepatocytes were plated on six-well Primaria cell culture dishes (BD Biosciences, Heidelberg, Germany) at 1.1Â10 6 viable cells per well in the following media as indicated: SCM (William's E medium containing 10% fetal bovine serum (PAA, Pasching, Austria)), 250 mg ml À1 ascorbic acid, 1 mg ml À1 bovine serum albumin, 5 mg ml À1 insulin, 10 mg ml À1 transferrin and 500 ng ml À1 hydrocortisone (all from Sigma Aldrich); HGM (SCM supplemented with EGF (HGM-E) or HGF (HGM-H) 0.1-100 mg ml À1 as indicated in the text (both PeproTech, Hamburg, Germany)); HDM, which consists of William's E, 5 mg ml À1 insulin and 10 nM dexamethasone; Castell medium; 13 and HCM (Lonza, Basel, Switzerland), according to manufacturer's specifications. Cells were incubated at 37 1C in a humidified environment at 5% CO 2 .
Stable gene transfer into primary mouse hepatocytes
After 2 h the medium was changed to remove non-attached or dead cells from the culture and cells were cultured in basal medium without fetal bovine serum for 4 h prior to ultra-short (4 h) or overnight transduction in 1 ml per well of the respective media. For transduction in suspension six-well, ultra-low attachment plates (Corning, Lowell, MA, USA) were used, where hepatocytes were seeded in either HGM-E (10 ng ml À1 ) or SCM containing the concentrated viral supernatant. After 4 h the cells were washed by centrifugation (100 g), resuspended in SCM and plated in six-well Primaria cell culture plates. The cells were washed and cultured with the respective medium after 24, 72 and 96 h.
Flow-cytometric analysis
Hepatocytes were analyzed by flow cytometry 5 days after transduction using an LSRII flow cytometer (Becton Dickinson, Franklin Lakes, NY, USA). Cells were trypsinized using a 10Â Trypsin/EDTA solution (Biochrom) at 37 1C until hepatocytes detached from the culture plate. A 1 ml volume of basal medium containing fetal bovine serum was added to stop the reaction. The hepatocytes were centrifuged at 100 g for 5 min at room temperature and resuspended in 1Â phosphate-buffered saline (Invitrogen) containing 1 mM EDTA (AppliChem, Darmstadt, Germany) and 0.5% bovine serum albumin (Sigma Aldrich). For dead cell exclusion, 10 mg of 7-aminoactinomycin-D (Sigma Aldrich) were used in a 100-ml staining volume using a yellow-green laser (561 nm) and a 670/14-nm filterset. The amount of transgene-expressing cells was determined by using a blue laser (488 nm) and a 525/50-nm filterset. Percentages of gated populations were calculated with the FlowJo software (Tree Star Inc., Ashland, OR, USA).
Analysis of total vector-derived DNA and 2-LTR circles
Total vector-derived copy numbers as well as the amount of 2-LTR circles were measured in a multiplex qPCR together with an intronic, genomic sequence for normalization. DNA was isolated by using the DNeasy Blood & Tissue kit according to manufacturer's instructions (Qiagen, Hilden, Germany). For detection of total vector-derived DNA, a primer/probe combination specific for the wPRE elements of the vector was used (wPRE forward: 5¢-GAG GAGTTGTGGCCCGTTGT-3¢, wPRE reverse: 5¢-TGACAGGTGGTGG CAATGCC-3¢; wPRE probe: 5¢-CY5-CTGTGTTTGCTGACGCAAC-black hole quencher-2 (BHQ-2)-3¢). For analysis of the 2-LTR circles, we used primers spanning the specific region of the LTR junctions (2-LTR forward: 5¢-T AGTGTGTGCCCGTCTGTTG-3¢, 2-LTR reverse: 5¢-TCGTTGGGAGTGAAT TAGCC-3¢; 2-LTR probe: 5¢-FAM-CCCTCAGACCCTTTTAGTCA-rhodamine (TAMRA)-3¢). We normalized the Cq values from wPRE and 2-LTR measurements by using an intronic sequence of the PTBP2 gene (primers provided by Tobias Mätzig, Department of Experimental Hematology, Hannover Medical School; PTBP2 forward: 5¢-TCTCCATTCCCTATGTTCATGC-3¢, PTBP2 reverse: 5¢-GTTCCCGCAGAATGGTGAGGTG-3¢; PTBP2 probe: 5¢-hexachloro-6-carboxyfluorescein-ATGTTCCTCGGACCAACTTG-black hole quencher-1 (BHQ-1)-3¢). For standard curves we first cloned the amplified sequences in the pCR4-TOPO vector, confirmed the correctness of the amplicons by sequencing and used plasmid dilutions covering 5-logs. All samples were analyzed in triplicates on a Roche Light Cycler 480 (LC480) system. The cycling conditions were 10 min at 95 1C, 45 cycles of 15 s at 95 1C, 30 s at 55 1C and 30s at 721C. Data were analyzed by using the LC480 software.
Analysis of integrated pro-viral DNA
The relative amount of integrated pro-virus was analyzed by following a published protocol, 23 with minor modifications. Briefly, DNA was isolated as described above and the highly redundant b1 sequence was amplified by annealing primers to the LTR, with a lambda-phage heel sequence at the 5¢-end and two outward-facing primers specific for the b1-elements. After a conventional first-round PCR, the amplicons were purified by using the QIAquick PCR Purification kit (Qiagen) to eliminate the primers from the first reaction. Afterwards, the integrants were analyzed by a primer/probe combination targeting the lambda-sequence and the LTR. The Cq values were normalized for the amount of initial genomic template DNA by using the PTBP2 sequence as described above. The results for the different treatment groups were analyzed by the comparative DDC t method.
Metabolic activity and proliferation
The Cell Proliferation Reagent WST-1 (Roche, Grenzach, Germany) is a readyto-use substrate, which measures the metabolic activity of viable cells. Hepatocytes were cultured for the indicated time periods in basal medium without phenol red, supplemented with growth factors as described above. After incubating cells with 1:10 WST-1 solution for 30 min, 100 ml of supernatants were transferred to a 96-well microtiter plate and measured by using an ELx800 Elisa reader (BioTek, Winooski, VT, USA) at 450 nm, with a reference wavelength of 600 nm.
Conventional proliferation was analyzed by the Click-iT EdU Flow Cytometry Assay Kit according to the manufacturer's instructions (Invitrogen). The nucleoside analog EdU is incorporated into DNA during active DNA synthesis. After a covalent reaction with a fluorochrome, labeled cells were detected by flow cytometry using a blue laser (488 nm) and a 525/50-nm filterset.
Hepatocyte transplantation
NOD.Cg-Prkdc scid C;Cg-Rag2 tm1Cgn Il2rg tm1Cgn Tg(Alb1-Plau)144Bri mice were generated by breeding NOD.Cg-Rag2 tm1Cgn Il2rg tm1Cgn -transgenic mice with NOD.Cg-Prkdc scid C-Tg(Alb1-Plau)144Bri mice. 24, [38] [39] [40] All animals had free access to food and water, and were handled in accordance with institutional guidelines. Hepatocytes were transduced overnight in adherence with HGM-E (10 ng ml À1 EGF) and detached from the culture plates by using Trypsin/EDTA as described above. With this method we recovered about 70-80% of the originally seeded cell number, with a viability of 80-90% as determined by Trypan Blue exclusion test. Intra-splenic hepatocyte transplantation was performed as described earlier, with minor modifications. 24 A total of 6Â10 5 transduced hepatocytes (54% transgene-positive cells in flow cytometry) were resuspended in 50 ml of 1Â phosphate-buffered saline and kept on ice until the time point of cell injection. Heterozygous animals were analyzed after 1 year.
Biometric and histological analysis of liver tissue
All four liver lobes of individual recipient animals were fixed in 4% formalin (Carl Roth, Karlsruhe, Germany) and embedded in paraffin blocks separately. Five sections (2 mm) from each lobe were cut from different levels. The total surface area of the sections and the area derived from transplanted cells (original magnification Â40) were measured by using the ImageJ software (NIH, Bethesda, MD, USA) and expressed as percentage.
Statistical analysis
Data were analyzed by using GraphPad Prism version 5 (GraphPad Software, La Jolla, CA, USA). Statistical differences between the various experimental groups were evaluated by t-test. To investigate the correlation between variables, we used Pearson's correlation. In all cases, differences were considered to be statistically significant when P-values were o0.05.
